<SEC-DOCUMENT>0001213900-14-004725-index.html : 20140707 <SEC-HEADER>0001213900-14-004725.hdr.sgml : 20140707 <ACCEPTANCE-DATETIME>20140707170749 ACCESSION NUMBER: 0001213900-14-004725 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20140707 DATE AS OF CHANGE: 20140707 EFFECTIVENESS DATE: 20140707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001388320 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 880378336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-197283 FILM NUMBER: 14963533 BUSINESS ADDRESS: STREET 1: 501 FIFTH AVENUE, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-300-2131 MAIL ADDRESS: STREET 1: 501 FIFTH AVENUE, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Cactus Ventures, Inc. DATE OF NAME CHANGE: 20070130 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>fs82014_actiniumpharma.htm <DESCRIPTION>REGISTRATION STATEMENT <TEXT> Document 1 - file: fs82014_actiniumpharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>2 <FILENAME>fs82014ex4i_actiniumpharma.htm <DESCRIPTION>SPECIMEN COMMON STOCK CERTIFICATE <TEXT> Document 2 - file: fs82014ex4i_actiniumpharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>fs82014ex5i_actiniumpharma.htm <DESCRIPTION>OPINION OF HISCOCK & BARCLAY, LLP <TEXT> Document 3 - file: fs82014ex5i_actiniumpharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>fs82014ex23i_actiniumpharma.htm <DESCRIPTION>CONSENT OF GBH CPAS, PC <TEXT> Document 4 - file: fs82014ex23i_actiniumpharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>img1.jpg <TEXT> Document 5 - file: img1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>img02.jpg <TEXT> Document 6 - file: img02.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>logo.jpg <TEXT> Document 7 - file: logo.jpg
</DOCUMENT> </SEC-DOCUMENT>